Particularly, in lung cancer, Wang et al. demonstrated that the TRBV20-1 usage was higher in tumor compared with normal lung tissues by sequencing the TCR-β CDR3 region [24]. The gene discussed is TRBV20-1; the disease is lung carcinoma.